Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15026353

Cancer Res. 2004 Mar 15 64 6 2127-33

Download in:

View as

General Info

PMID
15026353